| Authors: |
Joshi SS; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Catenacci DVT; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Peterson JD; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Zalupski MM; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Sehdev A; Division of Hematology/Oncology, Indiana University, Indianapolis, Indiana., Wade J; Decatur Memorial Hospital, Decatur, Illinois., Sadiq A; Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana., Picozzi VJ; Section of Hematology and Oncology, Virginia Mason Medical Center, Seattle, Washington., Amico A; The University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois., Marsh R; Northshore University Health System, Evanston, Illinois., Kozloff MF; UChicago Medicine Ingalls Memorial, Harvey, Illinois., Polite BN; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Kindler HL; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Sharma MR; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. manish.sharma@startmidwest.com. |